| abstract |
Disclosed are formulations and uses of the formulations for the treatment of malignant masses in mammals by administering directly into the malignant masses an injectable formulation comprising a therapeutically effective amount of dissolved or suspended in a biocompatible carrier chemotherapeutic agents. In certain preferred embodiments, the injectable formulation is a taxane (eg, paclitaxel), a podophyllotoxin derivative (eg, etoposide), or a camptothecin derivative (eg, hydroxycamptothecin). |